Recombinant Sumatran orangutan A1ACT Protein (aa 24-423) (VAng-2964Lsx)
Recombinant Sumatran orangutan Alpha 1 Antichymotrypsin Antigen is expressed in E. coli. (Uniprot ID: Q5R536)
Target
Alpha 1 Antichymotrypsin
Applications
SDS-PAGE; WB; ELISA.
Purity
> 95% pure by SDS-PAGE.
Introduction
A1ACT is an alpha globulin glycoprotein that is a member of the serpin superfamily. In humans, it is encoded by A1ACT gene. Alpha 1-antichymotrypsin inhibits the activity of certain enzymes called proteases, such as cathepsin G that is found in neutrophils, and chymases found in mast cells, by cleaving them into a different shape or conformation. This activity protects some tissues, such as the lower respiratory tract, from damage caused by proteolytic enzymes. This protein is produced in the liver, and is an acute phase protein that is induced during inflammation. Deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease.
Alternative Names
A1ACT; AACT; ACT; GIG24; GIG25
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.